GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Shanghai Allist Pharmaceuticals Co Ltd (SHSE:688578) » Definitions » Capital Expenditure

Shanghai Allist Pharmaceuticals Co (SHSE:688578) Capital Expenditure : ¥-281.18 Mil (TTM As of Mar. 2025)


View and export this data going back to 2020. Start your Free Trial

What is Shanghai Allist Pharmaceuticals Co Capital Expenditure?

Cash flow for capital expenditures refers to the funds spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

Shanghai Allist Pharmaceuticals Co's cash flow for capital expenditures for the three months ended in Mar. 2025 was ¥-58 Mil. Its cash flow for capital expenditures for the trailing twelve months (TTM) ended in Mar. 2025 was ¥-281.18 Mil.

Shanghai Allist Pharmaceuticals Co Capital Expenditure Historical Data

The historical data trend for Shanghai Allist Pharmaceuticals Co's Capital Expenditure can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shanghai Allist Pharmaceuticals Co Capital Expenditure Chart

Shanghai Allist Pharmaceuticals Co Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Capital Expenditure
Get a 7-Day Free Trial -88.46 -192.25 -143.84 -67.88 -270.22

Shanghai Allist Pharmaceuticals Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Capital Expenditure Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -46.91 -7.65 -179.52 -36.14 -57.87

Shanghai Allist Pharmaceuticals Co Capital Expenditure Calculation

Cash flow for capital expenditures refers to the funds spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

Capital Expenditure for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥-281.18 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Shanghai Allist Pharmaceuticals Co Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Shanghai Allist Pharmaceuticals Co Ltd (SHSE:688578) » Definitions » Capital Expenditure
Comparable Companies
SZSE:300759 SHSE:600161 BJSE:832982 SZSE:002252 SZSE:300122 SHSE:688278 SZSE:002653 SZSE:002007 SZSE:301301 SZSE:002821 VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX ALNY XBRU:UCB ONC BNTX XKRX:068270
Traded in Other Exchanges
N/A
Address
1118 HaLei Road & 1227 ZhangHeng Road, Building 1, 5th Floor, ZhangJiang Hi-Tech Park, PuDong District, Shanghai, CHN, 201203
Website
http://www.allist.com.cn
Shanghai Allist Pharmaceuticals Co Ltd is an innovative drug company in the field of cancer treatment.

Shanghai Allist Pharmaceuticals Co Headlines

No Headlines